Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus …
Jul 14, 2021 · Chronic graft-versus-host disease (GVHD), a major complication of allogeneic stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent...
Classification systems for chronic graft-versus-host disease
Chronic graft versus host disease (GVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation. Clinically, chronic GVHD is a pleiotropic, …
Updates in chronic graft-versus-host disease - American …
Dec 10, 2021 · Chronic graft-versus-host disease (GVHD) is the leading cause of late morbidity and mortality after allogeneic hematopoietic cell transplantation. Symptoms and manifestations …
慢性移植物抗宿主病(cGVHD)指异基因造血干细胞移植(allo-HSCT)后 ,受者在重建供者免疫的过程中,来源于供者的淋巴细胞攻击受者脏器产生的临床病理综合征(包括经典型cGVHD和重叠综合 …
HOME | Cgvh
The Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities is dedicated to conducting research on the complex intersections of emerging genomics …
慢性移植物抗宿主病（cGVHD）诊断与治疗中国专家共识（2021年 …
引用本文: 中华医学会血液学分会造血干细胞应用学组, 中国抗癌协会血液病转化委员会. 慢性移植物抗宿主病（cGVHD）诊断与治疗中国专家共识（2021年版） [J] . 中华血液学杂志, 2021, …
Measuring therapeutic response in chronic graft-versus-host ... - PubMed
In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document …
FDA approves ruxolitinib for chronic graft-versus-host disease
On September 22, 2021, the Food and Drug Administration approved ruxolitinib (Jakafi, Incyte Corp.) for chronic graft-versus-host disease (cGVHD) after failure of one or two lines of …
Steroid-refractory chronic graft-versus-host disease ... - Nature
Jul 3, 2021 · Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD...
Epidemiology and Treatment of Chronic Graft-versus-Host ... - PubMed
Chronic graft-versus-host disease (cGVHD) is a complication of hematopoietic cell transplantation (HCT). Although the clinical outcomes of cGVHD are well documented, few studies have …